|
|
|
|
|
|
Madrigal Pharmaceuticals Inc (MDGL)
|
|
15.655 +0.665 (+4.436%)
|
6/26/2017 12:58pm
|
|
Open:
|
15.000
|
Pre. Close:
|
14.990
|
|
High:
|
15.690
|
Low:
|
15.000
|
|
Volume:
|
10,728
|
Market Cap:
|
190.47M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
15.37 - 15.53
|
15.53 - 15.69
|
|
Low:
|
13.69 - 13.91
|
13.91 - 14.16
|
|
Close:
|
14.63 - 14.94
|
14.94 - 15.27
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-26 12:55:17 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 19.27 One year: 22.51
|
|
Support:
|
Support1: 14.39 Support2: 13.09
|
|
Resistance:
|
Resistance1:
16.50 Resistance2: 19.27
|
|
Pivot:
|
15.02 
|
|
Moving Averages:
|
MA(5): 14.66 MA(20): 15.09
MA(100): 15.69 MA(250): 14.15
|
|
MACD:
|
MACD(12,26):
-0.27 Signal(12,26,9): -0.31
|
|
%K %D:
|
%K(14,3): 72.18 %D(3): 57.85
|
|
RSI:
|
RSI(14): 53.29
|
|
52-Week:
|
High: 18.239
Low: 6.600 Change(%): 44.3
|
|
Average Vol(K):
|
3-Month: 27
10-Days 61
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.MDGL has closed below upper band by 32.2%. Bollinger Bands are 102.1% wider than normal. The large width of the bands suggest high volatility as compared to MDGL's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Fri, 22 Jul 2016 15:31:14 GMT
Madrigal Pharmaceuticals Completes Merger with Synta to Create Leading ...
Mon, 25 Jul 2016 20:03:49 GMT
14.99
Wed, 21 Jun 2017 12:56:15 GMT
Madrigal Pharmaceuticals Announces $35 Million Private Placement Offering
Mon, 19 Sep 2016 11:31:11 GMT
Madrigal Pharmaceuticals and Tarveda Therapeutics Announce Exclusive License ...
Thu, 11 May 2017 21:00:00 GMT
Madrigal Pharmaceuticals Reports 2017 First Quarter Financial Results
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
